Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects. - Wikidata - awgldk - TriplyDB

Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

http://www.wikidata.org/entity/Q41851858

about

Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lung Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.Lysophosphatidylcholine plays critical role in allergic airway disease manifestation.Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription Lipid-specific T cells and the skin.G2A Signaling Dampens Colitic Inflammation via Production of IFN-γ.Dysregulation of metabolic pathways in a mouse model of allergic asthma.Comparative Metabolomics Analysis of Cervicitis in Human Patients and a Phenol Mucilage-Induced Rat Model Using Liquid Chromatography Tandem Mass Spectrometry.Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry

P2860

Q28817762-4921D185-6FC2-4392-9C87-C67771C411AA Q33894887-4B7EE757-4761-480D-BCD0-D500283E71A6 Q36355889-D0DBCDF8-68B9-45CF-8EE8-C15188773F59 Q36916564-3C4E89DC-1087-42E6-B2FC-079EEB41E367 Q36990649-B33A2D34-36A6-4E7C-8519-265287EB8B28 Q38695972-4C88A1D1-F0C4-43EF-ACAF-62C49A5CBA8F Q38964257-93346720-1BFA-417A-950D-A3A14B198298 Q39611622-2D6E193F-0D00-49DB-9C91-96D8382EA9CB Q48221250-B39C9B35-3D37-466B-BC80-F9DB3F783881 Q52579254-722CFCCD-176E-4AAD-91E7-86DB1545A3E0 Q58760114-B17250A7-09BF-4EB8-B0C3-160E34FD409E

P2860

Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

http://www.wikidata.org/entity/Q41851858

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Bioactive lysophosphatidylchol ...... n lungs of asthmatic subjects.

@en

type

label

Bioactive lysophosphatidylchol ...... n lungs of asthmatic subjects.

@en

prefLabel

Bioactive lysophosphatidylchol ...... n lungs of asthmatic subjects.

@en

P1433

Q41851858-FC81E387-5214-440C-B439-942167701549

P1476

Q41851858-BDF6EC56-5CA6-4FBF-A385-F7861F697500

P2093

Q41851858-044616BD-9C1F-4F93-AE5B-89E27CD1352D

Q41851858-4CAFF55A-5AB9-4952-B03E-3FED99C8D136

Q41851858-CDB07BE1-D9AD-4B53-9C49-1C70DF911DBF

Q41851858-D2C40EA0-228E-4502-A537-8747F079D9AB

Q41851858-E073F7AE-7129-41B8-8D53-DB896BC0FBDF

Q41851858-E1574E35-F69A-4AF6-A366-33C2E3889AF9

Q41851858-E5E277B8-82F8-4EBF-BDBA-CD5ECCED4300

P2860

Q41851858-113E6BE7-6996-4A22-875E-A054DD0761BD

Q41851858-1CE1D7C0-A461-4008-A79F-DEA8CF0C8FC6

Q41851858-48A609CC-60DB-46A1-B367-3E45088961B2

Q41851858-49141818-51E1-4E48-9758-C336F51B6033

Q41851858-5C02F2E2-917E-410A-A751-7B841C3FD4E0

Q41851858-64CC1DBF-427E-4B20-A086-BCD497746378

Q41851858-68648C28-C651-4F71-A1A3-6A08468AC406

Q41851858-68942141-1619-4933-8C83-821A9DBA4A2A

Q41851858-78583D72-0BC9-4D43-B410-63B335DADBA3

Q41851858-80AF022E-AF7D-4593-9DD3-5DEB859A1CA5

P304

Q41851858-EEA8DD95-40F1-4571-A895-9B0009427557

P31

Q41851858-11CB2B95-BE2C-4219-9264-6FF9C70EB7A6

P356

Q41851858-6155E256-16AC-426B-9E74-9DC7F8B17482

P433

Q41851858-BDA452A1-C93D-45A7-B3C4-FBB7FCB70CA1

P478

Q41851858-6CB0C8F7-9BC0-47CF-AFD6-BC3CCD41ED2B

P50

Q41851858-A6C6B136-5A72-4ABC-9EB9-8B5BAA7C9F60

P577

Q41851858-14A126A8-16B0-47C8-8076-CA7C114CB490

P5875

Q41851858-B73B72E8-A9D2-47D1-A799-9626E27C5E6E

P698

Q41851858-8553017B-ED3F-4A7A-AD3D-8CE9849EBC43

P921

Q41851858-B5EBE6A6-8A40-4429-A5BF-46890EF8295D

P932

Q41851858-02090E4A-2FA8-48A3-922A-95F18E01F81B

P356

AAIR.2014.6.1.61

P1433

Allergy, Asthma & Immunology Research

P1476

Bioactive lysophosphatidylchol ...... n lungs of asthmatic subjects.

@en

P2093

Hazel Lum

http://www.w3.org/2001/XMLSchema#string

Larry L Thomas

http://www.w3.org/2001/XMLSchema#string

Mark Yoder

http://www.w3.org/2001/XMLSchema#string

Oksana Holian

http://www.w3.org/2001/XMLSchema#string

Sherry Kuo

http://www.w3.org/2001/XMLSchema#string

Yan Zhuge

http://www.w3.org/2001/XMLSchema#string

Yang Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration

Upregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4

T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

Antigen-induced generation of lyso-phospholipids in human airways.

Role of lysophosphatidylcholine (LPC) in atherosclerosis.

Phospholipase A2 structure/function, mechanism, and signaling.

Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction

Lung mast cells are a source of secreted phospholipases A2

Metabolism and atherogenic disease association of lysophosphatidylcholine.

P304

61-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4168/AAIR.2014.6.1.61

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Richard van Breemen

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259632297

http://www.w3.org/2001/XMLSchema#string

P698

24404395

http://www.w3.org/2001/XMLSchema#string

P921

P932

3881403

http://www.w3.org/2001/XMLSchema#string